Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 25;327(4):388-390.
doi: 10.1001/jama.2021.22749.

Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension

Joel G Ray  1 , Kasim E Abdulaziz  2 , Howard Berger  3 ; DOH-NET (Diabetes, Obesity, and Hypertension in Pregnancy Research Network)
Affiliations

Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension

Joel G Ray et al. JAMA. .

Abstract

This study estimates aspirin use for preeclampsia prevention in pregnant women with prepregnancy diabetes, obesity, chronic hypertension, and combinations of these factors in 2018-2020.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

References

    1. Bartsch E, Medcalf KE, Park AL, Ray JG; High Risk of Pre-eclampsia Identification Group . Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753. doi:10.1136/bmj.i1753 - DOI - PMC - PubMed
    1. LeFevre ML; US Preventive Services Task Force . Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161(11):819-826. doi:10.7326/M14-1884 - DOI - PubMed
    1. US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, et al. . Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement. JAMA. 2021;326(12):1186-1191. doi:10.1001/jama.2021.14781 - DOI - PubMed
    1. Berger H, Melamed N, Murray-Davis B, et al. ; Diabetes, Obesity and Hypertension in Pregnancy Research Network (DOH-NET) and the Southern Ontario Obstetrical Network (SOON) Investigators . Prevalence of pre-pregnancy diabetes, obesity, and hypertension in Canada. J Obstet Gynaecol Can. 2019;41(11):1579-1588.e2. doi:10.1016/j.jogc.2019.01.020 - DOI - PubMed
    1. Viguiliouk E, Park AL, Berger H, Geary MP, Ray JG. Low rates of aspirin use for the prevention of preeclampsia. J Obstet Gynaecol Can. 2017;39(9):722-723. doi:10.1016/j.jogc.2017.04.040 - DOI - PubMed

Publication types